MedTrace Logo

A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan

NCT01463254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 724

Last updated 2013-07-15

No results posted yet for this study

Summary

This will be a non-comparative prospective observational study of women using Femplant as a primary method of contraception in Pakistan.

Conditions

  • Contraception

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • FHI 360

    lead OTHER

Principal Investigators

  • Paul Feldblum, PhD · FHI 360

  • Syed Khurram Azmat, MD · Marie Stopes Society, Pakistan

  • Adrienne Testa · Marie Stopes Internatioanl

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01463254 on ClinicalTrials.gov